@inproceedings{inproceedings, title  = {{SUPERIOR DURABILITY OF RESPONSE WHEN A SECOND AUTOLOGOUS STEM CELL TRANSPLANT CONSOLIDATES BORTEZOMIB-CONTAINING RE-INDUCTION THERAPY FOR RELAPSED MULTIPLE MYELOMA (MM): FINAL RESULTS FROM THE BSBMT/UKMF MYELOMA X (INTENSIVE) TRIAL}},

 url = {{}},

 year = {{2014}},

 month = {{3}},

 author = {{Cook G and Williams C and Cairns DA and Chalmers A and Cavenagh J and Snowden J and Parrish C and Ashcroft J and Yong K and Cavet J and Hunter H et al}},

 volume = {{49}},

 journal = {{BONE MARROW TRANSPLANTATION}},

 pages = {{S72-S72}},

 note = {{Accessed on 2024/12/22}}}